Side-by-side comparison of AI visibility scores, market position, and capabilities
Data-driven farmer network and agricultural marketplace providing independent farmers with market intelligence, crop inputs, and financial services.
Farmers Business Network (FBN) is a San Carlos, California-based agricultural technology company that operates a data-driven farmer network and marketplace serving independent farmers across North America and Australia. FBN aggregates agronomic and market data from member farms to provide farmers with insights on seed performance, crop protection product efficacy, and input pricing benchmarks that help them make better planting decisions and negotiate better prices. FBN also operates a direct-to-farmer e-commerce marketplace for seeds, crop protection, and fertilizers under its own label, offering prices that undercut traditional distribution channels by eliminating intermediary markups. The company provides crop insurance, grain marketing, and working capital financing to complete the financial services available to FBN member farmers. Founded in 2014, FBN raised over $500M from investors including GV, Temasek, and T. Rowe Price, reaching a valuation above $3B. The company's model challenges the traditional agricultural supply chain by giving farmers data transparency and direct purchasing power previously available only to large agricultural operations.
$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.
ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.